Emerging evidence for non-pharmacologic interventions in reducing the burden of respiratory illnesses
- 4 February 2022
- journal article
- review article
- Published by Springer Nature in Internal and Emergency Medicine
- Vol. 17 (3) , 639-644
Abstract
The global pandemic caused by SARS-CoV-2 (COVID-19) has led to significant morbidity and mortality, and unprecedented economic and health system disruption. Non-pharmacologic interventions (NPIs) such as masking and physical distancing have formed the underpinnings of COVID-19 infection control strategies. Concomitantly, numerous jurisdictions have seen a decrease in hospitalizations for non-COVID-19 respiratory illnesses (NCRIs) such as asthma, community-acquired pneumonia, influenza, and chronic obstructive pulmonary disease relative to pre-pandemic levels. These associations give rise to a number of testable hypotheses regarding the efficacy of NPIs in reducing the substantial burden of NCRIs. Here, we review emerging perspectives on the role of NPIs in NCRI prevention with the ultimate goal of informing future research and public policy development as we move into what may be the endemic phase of the COVID-19 pandemic.Keywords
This publication has 33 references indexed in Scilit:
- Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemicRespiratory Medicine, 2020
- Disposable masks: Disinfection and sterilization for reuse, and non-certified manufacturing, in the face of shortages during the COVID-19 pandemicSafety Science, 2020
- The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countriesScience, 2020
- Estimating the effects of non-pharmaceutical interventions on COVID-19 in EuropeNature, 2020
- Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plansBritish Journal of Surgery, 2020
- The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling studyThe Lancet Public Health, 2020
- Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthmaPLOS ONE, 2020
- Impact and prevention of severe exacerbations of COPD: a review of the evidenceInternational Journal of Chronic Obstructive Pulmonary Disease, 2017
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Asthma exacerbations {middle dot} 1: EpidemiologyThorax, 2006